Indication
Acute hepatic failure
Acute hepatic failure is a critical, life-threatening clinical syndrome defined by a rapid loss of hepatocyte function occurring in individuals without preexisting chronic liver disease or cirrhosis. Read more about Acute hepatic failure
40 drugs 13 manufacturers
Drugs that treat it
Common Acute hepatic failure therapies.
PLASBUMIN-5 (albumin human)
ALBUMINAR-25 (albumin human)
ALBUMINAR-5 (albumin human)
FLEXBUMIN (albumin human)
ALBUTEIN (albumin human)
ALBUTEIN (albumin human)
BUMINATE (albumin human)
ALBUKED-25 (albumin human)
News & literature
Coming soonRelated codes
Coming soonRelated conditions & guidelines
Coming soonAcute hepatic failure is a critical, life-threatening clinical syndrome defined by a rapid loss of hepatocyte function occurring in individuals without preexisting chronic liver disease or cirrhosis.
Primarily affecting the hepatic and central nervous systems, it is pathophysiologically driven by massive hepatocellular necrosis or severe dysfunction resulting from causes such as drug-induced hepatotoxicity, viral hepatitis, ischemic injury, or autoimmune insults.
Clinically, it is characterized by the sudden onset of impaired hepatic synthetic function manifesting as coagulopathy—typically an international normalized ratio (INR) of 1.5 or greater—alongside altered mental status due to hepatic encephalopathy, evolving over an illness duration of less than 26 weeks.
- nih.gov
Acute hepatic failure is a critical, life-threatening clinical syndrome defined by a rapid loss of hepatocyte function occurring in individuals without preexisting chronic liver disease or cirrhosis Clinically, it is characterized by the sudden onset of impaired hepatic synthetic function manifesting as coagulopathy—typically an international normalized ratio (INR) of 1.5 or greater—alongside altered mental status due to hepatic encephalopathy, evolving over an illness duration of less than 26 w...
- nih.gov
Acute hepatic failure is a critical, life-threatening clinical syndrome defined by a rapid loss of hepatocyte function occurring in individuals without preexisting chronic liver disease or cirrhosis
- nih.gov
Primarily affecting the hepatic and central nervous systems, it is pathophysiologically driven by massive hepatocellular necrosis or severe dysfunction resulting from causes such as drug-induced hepatotoxicity, viral hepatitis, ischemic injury, or autoimmune insults
- nih.gov
Primarily affecting the hepatic and central nervous systems, it is pathophysiologically driven by massive hepatocellular necrosis or severe dysfunction resulting from causes such as drug-induced hepatotoxicity, viral hepatitis, ischemic injury, or autoimmune insults
- guidelinecentral.com
Primarily affecting the hepatic and central nervous systems, it is pathophysiologically driven by massive hepatocellular necrosis or severe dysfunction resulting from causes such as drug-induced hepatotoxicity, viral hepatitis, ischemic injury, or autoimmune insults Clinically, it is characterized by the sudden onset of impaired hepatic synthetic function manifesting as coagulopathy—typically an international normalized ratio (INR) of 1.5 or greater—alongside altered mental status due to hepatic...
- surgicalcriticalcare.net
Clinically, it is characterized by the sudden onset of impaired hepatic synthetic function manifesting as coagulopathy—typically an international normalized ratio (INR) of 1.5 or greater—alongside altered mental status due to hepatic encephalopathy, evolving over an illness duration of less than 26 weeks
Personalize your experience
Follow Acute hepatic failure and get updates as they land.
Already a member? Sign in
Follow an indication and get alerts when its drugs, labels, or guidelines change
Save any drug on this page to your favorites, synced across devices
AI-curated peer-reviewed research, summarized for your specialty
A morning digest of indication-relevant updates, when you want it
Sign in to follow this indication
Following an indication requires a free Physicians Office Resource account.